Our next-generation viral immunotherapies pack a powerful trio of attributes – selective attack, potent destruction, and broad immune stimulation – to enable the potential to transform outcomes for patients.

News Releases

Contact Information

ir@oncorus.com
media@oncorus.com

Toolkit

Email Alerts

RSS

Print

Email Page

Search

Top